Endoscopic ultrasound-guided oncologic therapy for pancreatic cancer

Rei Suzuki, Atsushi Irisawa, Manoop S Bhutani, Rei Suzuki, Atsushi Irisawa, Manoop S Bhutani

Abstract

Since the development of endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) in the early 1990s, its application has been extended to various diseases. For pancreatic cancer, EUS-FNA can obtain specimens from the tumor itself with fewer complications than other methods. Interventional EUS enables various therapeutic options: local ablation, brachytherapy, placement of fiducial markers for radiotherapy, and direct injection of antitumor agents into cancer. This paper will focus on EUS-guided oncologic therapy for pancreatic cancer.

References

    1. Vilmann P, Jacobsen GK, Henriksen FW, Hancke S. Endoscopic ultrasonography with guided fine needle aspiration biopsy in pancreatic disease. Gastrointestinal Endoscopy. 1992;38(2):172–173.
    1. Chang KJ, Irisawa A. EUS 2008 Working Group document: evaluation of EUS-guided injection therapy for tumors. Gastrointestinal Endoscopy. 2009;69(2, supplement):S54–S58.
    1. Seo DW. EUS-guided antitumor therapy for pancreatic tumors. Gut and Liver. 2010;4(supplement 1):S76–S81.
    1. Hara K, Yamao K, Mizuno N, et al. Interventional endoscopic ultrasonography for pancreatic cancer. World Journal of Clinical Oncology. 2011;2(2):108–114.
    1. Sener SF, Fremgen A, Menck HR, Winchester DP. Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985–1995, using the National Cancer Database. Journal of the American College of Surgeons. 1999;189(1):1–7.
    1. Regula J, MacRobert AJ, Gorchein A, et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX—a pilot study. Gut. 1995;36(1):67–75.
    1. Overholt BF, Panjehpour M, Tefftellar E, Rose M. Photodynamic therapy for treatment of early adenocarcinoma in Barrett’s esophagus. Gastrointestinal Endoscopy. 1993;39(1):73–76.
    1. Bown SG, Rogowska AZ, Whitelaw DE, et al. Photodynamic therapy for cancer of the pancreas. Gut. 2002;50(4):549–557.
    1. Chan HH, Nishioka NS, Mino M, et al. EUS-guided photodynamic therapy of the pancreas: a pilot study. Gastrointestinal Endoscopy. 2004;59(1):95–99.
    1. Yusuf TE, Matthes K, Brugge WR. EUS-guided photodynamic therapy with verteporfin for ablation of normal pancreatic tissue: a pilot study in a porcine model (with video) Gastrointestinal Endoscopy. 2008;67(6):957–961.
    1. Goldberg SN, Mallery S, Gazelle GS, Brugge WR. EUS-guided radiofrequency ablation in the pancreas: results in a porcine model. Gastrointestinal Endoscopy. 1999;50(3):392–401.
    1. Carrara S, Arcidiacono PG, Albarello L, et al. Endoscopic ultrasound-guided application of a new hybrid cryotherm probe in porcine pancreas: a preliminary study. Endoscopy. 2008;40(4):321–326.
    1. Carrara S, Arcidiacono PG, Albarello L, et al. Endoscopic ultrasound-guided application of a new internally gas-cooled radiofrequency ablation probe in the liver and spleen of an animal model: a preliminary study. Endoscopy. 2008;40(9):759–763.
    1. Di Matteo F, Martino M, Rea R, et al. EUS-guided Nd:YAG laser ablation of normal pancreatic tissue: a pilot study in a pig model. Gastrointestinal Endoscopy. 2010;72(2):358–363.
    1. Kim J, Chung DJ, Jung SE, Cho SH, Hahn S-T, Lee JM. Therapeutic effect of high-intensity focused ultrasound combined with transarterial chemoembolisation for hepatocellular carcinoma <5 cm: comparison with transarterial chemoembolisation monotherapy—preliminary observations. British Journal of Radiology. 2012;85(1018):e940–e946.
    1. Leslie T, Ritchie R, Illing R, et al. High-intensity focused ultrasound treatment of liver tumours: post-treatment MRI correlates well with intra-operative estimates of treatment volume. British Journal of Radiology. 2012;85(1018):1363–1370.
    1. Hwang J, Farr N, Morrison K, et al. Development of ana EUS-guided high-intensity focused ultrasound endoscope. Gastrointestinal Endoscopy. 2011;73(4S):p. AB155.
    1. Zhongmin W, Yu L, Fenju L, Kemin C, Gang H. Clinical efficacy of CT-guided iodine-125 seed implantation therapy in patients with advanced pancreatic cancer. European Radiology. 2010;20(7):1786–1791.
    1. Kishi K, Sonomura T, Shirai S, et al. Brachytherapy reirradiation with hyaluronate gel injection of paraaortic lymphnode metastasis of pancreatic cancer: paravertebral approach—a technical report with a case. Journal of Radiation Research. 2011;52(6):840–844.
    1. Sun S, Qingjie L, Qiyong G, Mengchun W, Bo Q, Hong X. EUS-guided interstitial brachytherapy of the pancreas: a feasibility study. Gastrointestinal Endoscopy. 2005;62(5):775–779.
    1. Jin Z, Du Y, Li Z, Jiang Y, Chen J, Liu Y. Endoscopic ultrasonography-guided interstitial implantation of iodine 125-seeds combined with chemotherapy in the treatment of unresectable pancreatic carcinoma: a prospective pilot study. Endoscopy. 2008;40(4):314–320.
    1. Xie DR, Liang HL, Wang Y, Guo SS, Yang Q. Meta-analysis on inoperable pancreatic cancer: a comparison between gemcitabine-based combination therapy and gemcitabine alone. World Journal of Gastroenterology. 2006;12(43):6973–6981.
    1. Pishvaian AC, Collins B, Gagnon G, Ahlawat S, Haddad NG. EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignancies. Gastrointestinal Endoscopy. 2006;64(3):412–417.
    1. Varadarajulu S, Trevino JM, Shen S, Jacob R. The use of endoscopic ultrasound-guided gold markers in image-guided radiation therapy of pancreatic cancers: a case series. Endoscopy. 2010;42(5):423–425.
    1. Chang KJ, Nguyen PT, Thompson JA, et al. Phase I clinical trial of allogeneic mixed lymphocyte culture (cytoimplant) delivered by endoscopic ultrasound—guided fine-needle injection in patients with advanced pancreatic carcinoma. Cancer. 2000;88(6):1325–1335.
    1. Akiyama Y, Maruyama K, Nara N, et al. Antitumor effects induced by dendritic cell-based immunotherapy against established pancreatic cancer in hamsters. Cancer Letters. 2002;184(1):37–47.
    1. Irisawa A, Takagi T, Kanazawa M, et al. Endoscopic ultrasound-guided fine-needle injection of immature dendritic cells into advanced pancreatic cancer refractory to gemcitabine: a pilot study. Pancreas. 2007;35(2):189–190.
    1. Hirooka Y, Itoh A, Kawashima H, et al. A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer. Pancreas. 2009;38(3):e69–e74.
    1. Yu JS, Liu G, Ying H, Yong WH, Black KL, Wheeler CJ. Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Research. 2004;64(14):4973–4979.
    1. Mulvihill S, Warren R, Venook A, et al. Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial. Gene Therapy. 2001;8(4):308–315.
    1. Hecht JR, Bedford R, Abbruzzese JL, et al. A phase I/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma. Clinical Cancer Research. 2003;9(2):555–561.
    1. Sharma A, Mani S, Hanna N, et al. An open-label, phase I, dose-escalation study of tumor necrosis factor-α (TNFerade biologic) gene transfer with radiation therapy for locally advanced, recurrent, or metastatic solid tumors. Human Gene Therapy. 2001;12(9):1109–1131.
    1. Senzer N, Mani S, Rosemurgy A, et al. TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumors. Journal of Clinical Oncology. 2004;22(4):592–601.
    1. Hecht JR, Farrell JJ, Senzer N, et al. EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study. Gastrointestinal Endoscopy. 2012;75(2):332–338.

Source: PubMed

3
Prenumerera